InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Last Andrew J., Chief Operating Officer. Director active across 3 companies, notably OncoCyte Corp. In total, 5 filings have been published. The latest transaction was disclosed on 29 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
01,000 shares0
Bio-Rad A Common Stock
SEC:0001062993-22-011169:0·
€505,4342,000 shares@ €252.7171100.0% of flow
Bio-Rad A Common Stock
SEC:0001062993-21-008244·
€505,4342,000 shares@ €252.717150.0% of flow
Bio-Rad A Common Stock
SEC:0001062993-21-008244:0·
€17,2356,993 shares@ €2.4646100.0% of flow
Common Stock
SEC:0001493152-21-014342·
€17,2356,993 shares@ €2.464650.0% of flow
Common Stock
SEC:0001493152-21-014342:0·
5 of 5 declarations
About Last Andrew J.
Andrew J. Last is a Board Member and the Chief Operating Officer at OncoCyte Corp and BIO-RAD LABORATORIES, INC. He is responsible for managing operations and the company's strategy. Last plays a key role in optimizing processes and implementing new initiatives.
